RNA activation
RNA Activation (RNAa) is a cellular process through which small double-stranded RNA molecules (dsRNAs) induce gene expression. Unlike RNA interference (RNAi), which leads to gene silencing, RNAa enhances the transcription of specific genes. This mechanism has significant implications for understanding gene regulation and holds potential for therapeutic applications in treating various diseases.
Mechanism
RNA activation operates through dsRNAs targeting gene promoters. These dsRNAs, often referred to as small activating RNAs (saRNAs), bind to the promoter regions of specific genes. This binding recruits the Argonaute protein family and other transcription factors, leading to changes in the chromatin structure that make the DNA more accessible for transcription. Consequently, RNA Polymerase II is able to initiate transcription more effectively, resulting in increased gene expression.
Discovery
The phenomenon of RNAa was first described in 2006 by researchers at the University of Massachusetts Medical School. They observed that introducing small dsRNAs into human cells could specifically upregulate the expression of certain genes, a process that was distinct from the well-characterized RNAi pathway.
Applications
RNAa has potential applications in both basic research and clinical therapy. In research, it can be used to upregulate genes to study their function. Clinically, RNAa has the potential to treat diseases by activating the expression of genes that can counteract disease processes. For example, activating tumor suppressor genes could provide a new approach to cancer therapy. Additionally, RNAa could be used to treat genetic disorders caused by insufficient protein production.
Challenges and Future Directions
Despite its potential, the application of RNAa faces several challenges. Delivering saRNAs into cells efficiently and specifically targeting genes without off-target effects are significant hurdles. Furthermore, understanding the long-term effects of gene activation in humans requires more research.
See Also
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD